Works matching IS 13419625 AND DT 2022 AND VI 27 AND IP 4

Results: 22
    1

    Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.

    Published in:
    2022
    By:
    • Tohi, Yoichiro;
    • Kato, Takuma;
    • Matsumoto, Ryuji;
    • Shinohara, Nobuo;
    • Shiga, Kenichiro;
    • Yokomizo, Akira;
    • Nakamura, Masaki;
    • Kume, Haruki;
    • Mitsuzuka, Koji;
    • Sasaki, Hiroshi;
    • Egawa, Shin;
    • Matsumura, Masafumi;
    • Hashine, Katsuyoshi;
    • Inokuchi, Junichi;
    • Eto, Masatoshi;
    • Baba, Haruki;
    • Ichikawa, Tomohiko;
    • Kinoshita, Hidefumi;
    • Matsuda, Tadashi;
    • Kakehi, Yoshiyuki
    Publication type:
    Correction Notice
    2

    Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases

    Published in:
    2022
    By:
    • Ono, Masanori;
    • Matsumoto, Kimikazu;
    • Boku, Narikazu;
    • Fujii, Nobuharu;
    • Tsuchida, Yumi;
    • Furui, Tatsuro;
    • Harada, Miyuki;
    • Kanda, Yoshinobu;
    • Kawai, Akira;
    • Miyachi, Mitsuru;
    • Murashima, Atsuko;
    • Nakayama, Robert;
    • Nishiyama, Hiroyuki;
    • Shimizu, Chikako;
    • Sugiyama, Kazuhiko;
    • Takai, Yasushi;
    • Fujio, Keishi;
    • Morishige, Ken-Ichirou;
    • Osuga, Yutaka;
    • Suzuki, Nao
    Publication type:
    Correction Notice
    3
    4

    Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 781, doi. 10.1007/s10147-022-02121-z
    By:
    • Morizane, Shuichi;
    • Honda, Masashi;
    • Shimizu, Ryutaro;
    • Tsounapi, Panagiota;
    • Teraoka, Shogo;
    • Yumioka, Tetsuya;
    • Yamaguchi, Noriya;
    • Kawamoto, Bunya;
    • Iwamoto, Hideto;
    • Hikita, Katsuya;
    • Takenaka, Atsushi
    Publication type:
    Article
    5

    First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 695, doi. 10.1007/s10147-022-02120-0
    By:
    • John, Thomas;
    • Sakai, Hiroshi;
    • Ikeda, Satoshi;
    • Cheng, Ying;
    • Kasahara, Kazuo;
    • Sato, Yuki;
    • Nakahara, Yoshiro;
    • Takeda, Masayuki;
    • Kaneda, Hiroyasu;
    • Zhang, Helong;
    • Maemondo, Makoto;
    • Minato, Koichi;
    • Hisada, Takeshi;
    • Misumi, Yuki;
    • Satouchi, Miyako;
    • Hotta, Katsuyuki;
    • Li, Ang;
    • Oukessou, Abderrahim;
    • Lu, Shun
    Publication type:
    Article
    6

    Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B).

    Published in:
    2022
    By:
    • Tsubata, Yukari;
    • Watanabe, Kana;
    • Saito, Ryota;
    • Nakamura, Atsushi;
    • Yoshioka, Hiroshige;
    • Morita, Mami;
    • Honda, Ryoichi;
    • Kanaji, Nobuhiro;
    • Oizumi, Satoshi;
    • Jingu, Daisuke;
    • Nakagawa, Taku;
    • Nakazawa, Kensuke;
    • Mouri, Atsuto;
    • Takeuchi, Susumu;
    • Furuya, Naoki;
    • Akazawa, Yuki;
    • Miura, Kiyotaka;
    • Ichihara, Eiki;
    • Maemondo, Makoto;
    • Morita, Satoshi
    Publication type:
    Correction Notice
    7
    8

    Cancer risk and genotype–phenotype correlation in Japanese patients with Cowden syndrome.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 639, doi. 10.1007/s10147-022-02116-w
    By:
    • Teramae, Satoshi;
    • Muguruma, Naoki;
    • Okamoto, Koichi;
    • Oseto, Kumiko;
    • Nishikawa, Ryutaro;
    • Tanoue, Takayuki;
    • Hirata, Keiji;
    • Yanai, Shunichi;
    • Matsumoto, Takayuki;
    • Shimizu, Seiji;
    • Miwa, Jun;
    • Sasaki, Yu;
    • Yashima, Kazuo;
    • Ohnuma, Hiroyuki;
    • Sato, Yasushi;
    • Kitayama, Yoshitaka;
    • Ohda, Yoshio;
    • Yamauchi, Atsushi;
    • Sanomura, Yoji;
    • Tanaka, Kumiko
    Publication type:
    Article
    9
    10
    11

    Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 676, doi. 10.1007/s10147-021-02113-5
    By:
    • Oizumi, Satoshi;
    • Takamura, Kei;
    • Harada, Toshiyuki;
    • Tachihara, Motoko;
    • Morikawa, Naoto;
    • Honda, Ryoichi;
    • Watanabe, Satoshi;
    • Asao, Tetsuhiko;
    • Kunisaki, Mamoru;
    • Fukuhara, Tatsuro;
    • Noro, Rintaro;
    • Kikuchi, Eiki;
    • Tsutani, Yasuhiro;
    • Tenma, Toshiyuki;
    • Kobayashi, Kunihiko;
    • Dosaka-Akita, Hirotoshi
    Publication type:
    Article
    12
    13
    14
    15

    Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).

    Published in:
    International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 684, doi. 10.1007/s10147-022-02114-y
    By:
    • Nakasya, Akio;
    • Hagiwara, Yuya;
    • Ikoma, Tatsuki;
    • Kurioka, Yusuke;
    • Matsumoto, Toshihiko;
    • Yamamoto, Yoshiyuki;
    • Tsuduki, Takao;
    • Kajiwara, Takeshi;
    • Moriwaki, Toshikazu;
    • Nishina, Tomohiro;
    • Yamashita, Natsumi;
    • Hyodo, Ichinosuke
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22